 | |
- close
- close
Globe Newswire
Jan 25
Comment
PALO ALTO, Calif., Jan. 25, 2010 (GLOBE NEWSWIRE) -- StemCells, Inc. (Nasdaq:STEM) announced today the launch of GS1-R™, the first commercially available medium to enable the derivation, maintenance and growth of true (germline competent) rat
Globe Newswire
Jan 19
Comment
PASCAGOULA, Miss., Jan. 19, 2010 (GLOBE NEWSWIRE) -- Northrop Grumman Corporation’s (NYSE:NOC) Shipbuilding sector has awarded $82,000 in grants to Gulf Coast school districts in Louisiana, Mississippi and Alabama to use for science, technology,
Globe Newswire
Jan 12
Comment
DALLAS, Jan. 12, 2010 (GLOBE NEWSWIRE) -- BeaconEquity.com announces an investment report featuring biopharmaceutical company StemCell Inc. (Nasdaq:STEM). The report includes financial, comparative and investment analyses, and industry information
TheStreet.com
Jan 8
Comment
Several stocks trading near $5 were moving on above-average volume during Wednesday's session.
Business Wire
Dec 15
Comment
StemCells, Inc. (NASDAQ:STEM) announced today that it has received a Notice of Allowance and a Notice of Issuance from the U.S. Patent and Trademark Office for two patents claiming technologies for the establishment and maintenance of cell
PR Newswire
Dec 10
Comment
NEWCASTLE, United Kingdom, Dec. 10 /PRNewswire/ -- Newly published research, by investigators, at the North East England Stem Cell Institute (NESCI) in the journal STEM CELLS reported the first successful treatment of eight patients with "Limbal Stem
PR Newswire
Dec 8
Comment
BALTIMORE, Dec. 8 /PRNewswire/ -- The founders of Possibility STEM Preparatory Academy, Prince Georges County's newest public charter school, believe that the school's name will send an important message to students and parents throughout the County.
Life Science Lab
Dec 6
Comment
StemCells has received approval by the National Institutes of Health (NIH) of the first 13 human embryonic stem cell (hESC) lines for use in NIH-funded research under the NIH Guidelines for Human Stem Cell Research adopted in July 2009.
Business Wire
Dec 3
Comment
StemCells, Inc. (NASDAQ: STEM) announced today that it welcomes the approval yesterday by the National Institutes of Health (NIH) of the first 13 human embryonic stem cell (hESC) lines for use in NIH-funded research under the NIH Guidelines for Human
TheStreet.com
Dec 2
Comment
Several stocks trading near $5 were moving on above-average volume during Wednesday's session.
Suggest other news sources for this topic
Thank you for your suggestion
more ▼WIKI ANALYSIS
WIKI ANALYSIS
 |
The article on this company has not been written yet. If you're the first person to write this article, it's a sure thing that you'll be credited as a Top Contributor. For tips on getting started, check out the sample article. |
STEM AT A GLANCE
References
| ||||||
|
|
